Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
Inhibition of the metabolic enzyme ATP-citrate lyase can attenuate atherosclerosis by preventing dyslipidemia and potentially also by reducing macrophage-mediated inflammation. Here, the authors show that specific targeting of ACLY in macrophages results in more stable atherosclerotic plaques.
Main Authors: | Jeroen Baardman, Sanne G. S. Verberk, Saskia van der Velden, Marion J. J. Gijbels, Cindy P. P. A. van Roomen, Judith C. Sluimer, Jelle Y. Broos, Guillermo R. Griffith, Koen H. M. Prange, Michel van Weeghel, Soufyan Lakbir, Douwe Molenaar, Elisa Meinster, Annette E. Neele, Gijs Kooij, Helga E. de Vries, Esther Lutgens, Kathryn E. Wellen, Menno P. J. de Winther, Jan Van den Bossche |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-20141-z |
Similar Items
-
Succinate Is an Inflammation-Induced Immunoregulatory Metabolite in Macrophages
by: Karl J. Harber, et al.
Published: (2020-09-01) -
Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
by: Annette E. Neele, et al.
Published: (2021-01-01) -
Myeloid-Specific Acly Deletion Alters Macrophage Phenotype <i>In Vitro</i> and <i>In Vivo</i> without Affecting Tumor Growth
by: Kyra E. de Goede, et al.
Published: (2021-06-01) -
Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis
by: Rosario Luque-Martin, et al.
Published: (2019-10-01) -
Targeting the ACOD1-itaconate axis stabilizes atherosclerotic plaques
by: Karl J. Harber, et al.
Published: (2024-04-01)